<DOC>
	<DOCNO>NCT01905163</DOCNO>
	<brief_summary>This prospective nonrandomized multicenter phase II study , evaluate possibility perform laparoscopic interval debulking minimum 3 cycle chemotherapy highly chemo-sensitive patient advanced ovarian , tubal cancer primary peritoneal .</brief_summary>
	<brief_title>Feasibility Interval Debulking Surgery Laparoscopy Peritoneal Carcinosis Chemosensitive Patients</brief_title>
	<detailed_description />
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<criteria>Age &gt; = 18 year performance status WHO &lt; 2 Epithelial ovarian , fallopian tube primary peritoneal carcinoma ( histologically confirm ) Unresectable disease FIGO stage IV disease proven image ( CT Scan PET CT ) and/or diffuse extensive carcinosis consider unresectable advanced FIGO stage IIIc ; patient unable support radical primary surgery age , comorbidities alter general condition . No previous debulking surgery neoadjuvant chemotherapy . Patients treat minimum 3 cycle platinumbased neoadjuvant chemotherapy . Response chemotherapy radiologically confirm ( ScanTAP ) prior interval surgery : No evidence peritoneal supramesocolic carcinomatosis ; Residual pelvic mass small 10 cm ; Absence suspect supracentimeter retroperitoneal lymphadenopathy able read , write understand French . Member Social Security scheme . write informed consent . Patient unable support laparoscopy psychiatric condition social geographic situation would impede appropriate study participation Concomitant participation another clinical trial evaluate surgical treatment ( interfere evaluation main endpoint )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Laparoscopy , interval debulking surgery</keyword>
</DOC>